Silke Sohn1, Irina Tiper1, Emily Japp2, Wenji Sun1, Katherine Tkaczuk2, Tonya J Webb3. 1. Department of Microbiology and Immunology, University of Maryland School of Medicine, Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD 21201, USA. 2. Department of Medicine, University of Maryland School of Medicine, Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD 21201, USA. 3. Department of Microbiology and Immunology, University of Maryland School of Medicine, Marlene and Stewart Greenebaum Cancer Center, Baltimore, MD 21201, USA. Electronic address: twebb@som.umaryland.edu.
Abstract
INTRODUCTION: NKT cells comprise a rare, but important subset of T cells which account for ~0.2% of the total circulating T cell population. NKT cells are known to have anti-tumor functions and rapidly produce high levels of cytokines following activation. Several clinical trials have sought to exploit the effector functions of NKT cells. While some studies have shown promise, NKT cells are approximately 50% lower in cancer patients compared to healthy donors of the same age and gender, thus limiting their therapeutic efficacy. These studies indicate that baseline levels of activation should be assessed before initiating an NKT cell based immunotherapeutic strategy. AIM: The goal of this study was to develop a sensitive method to rapidly assess NKT cell function. METHODS: We utilized artificial antigen presenting cells in combination with qPCR in order to determine NKT cell function in peripheral blood mononuclear cells from healthy donors and breast cancer patients. RESULTS: We found that NKT cell activation can be detected by qPCR, but not by ELISA, in healthy donors as well as in breast cancer patients following four hour stimulation. CONCLUSION: This method utilizing CD1d-expressing aAPCs will enhance our knowledge of NKT cell biology and could potentially be used as a novel tool in adoptive immunotherapeutic strategies.
INTRODUCTION: NKT cells comprise a rare, but important subset of T cells which account for ~0.2% of the total circulating T cell population. NKT cells are known to have anti-tumor functions and rapidly produce high levels of cytokines following activation. Several clinical trials have sought to exploit the effector functions of NKT cells. While some studies have shown promise, NKT cells are approximately 50% lower in cancerpatients compared to healthy donors of the same age and gender, thus limiting their therapeutic efficacy. These studies indicate that baseline levels of activation should be assessed before initiating an NKT cell based immunotherapeutic strategy. AIM: The goal of this study was to develop a sensitive method to rapidly assess NKT cell function. METHODS: We utilized artificial antigen presenting cells in combination with qPCR in order to determine NKT cell function in peripheral blood mononuclear cells from healthy donors and breast cancerpatients. RESULTS: We found that NKT cell activation can be detected by qPCR, but not by ELISA, in healthy donors as well as in breast cancerpatients following four hour stimulation. CONCLUSION: This method utilizing CD1d-expressing aAPCs will enhance our knowledge of NKT cell biology and could potentially be used as a novel tool in adoptive immunotherapeutic strategies.
Authors: Famke L Schneiders; Renée C G de Bruin; Alfons J M van den Eertwegh; Rik J Scheper; C René Leemans; Ruud H Brakenhoff; Johannes A Langendijk; Henk M W Verheul; Tanja D de Gruijl; Johan W Molling; Hans J van der Vliet Journal: J Clin Oncol Date: 2012-01-17 Impact factor: 44.544
Authors: T I Prigozy; O Naidenko; P Qasba; D Elewaut; L Brossay; A Khurana; T Natori; Y Koezuka; A Kulkarni; M Kronenberg Journal: Science Date: 2001-01-26 Impact factor: 47.728
Authors: T Kawano; T Nakayama; N Kamada; Y Kaneko; M Harada; N Ogura; Y Akutsu; S Motohashi; T Iizasa; H Endo; T Fujisawa; H Shinkai; M Taniguchi Journal: Cancer Res Date: 1999-10-15 Impact factor: 12.701
Authors: S M Tahir; O Cheng; A Shaulov; Y Koezuka; G J Bubley; S B Wilson; S P Balk; M A Exley Journal: J Immunol Date: 2001-10-01 Impact factor: 5.422